<DOC>
	<DOC>NCT01034865</DOC>
	<brief_summary>To identify risk factors for the development and diagnosis of hepatocellular CA in patients with chronic hepatitis C and to use the data to ultimately develop an effective screening program.</brief_summary>
	<brief_title>Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease &amp;Hepatocellular CA</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Carcinoma, Hepatocellular</mesh_term>
	<criteria>*For both experimental subjects and controls: 1. Patients between older than 18 years of age of all ethnic backgrounds and genders. 2. Patients with chronic liver disease For Experimental Subjects Only: 1. Patients with HCC with either: (i) a hepatic mass larger or equal to 5cm, or; (ii) a hepatic mass lesion confirmed by fine needle aspirate (FNA) or by pathology in the cases of surgical resection, or; (iii) a hepatic mass lesion with characteristic CT or MRI or angiographic appearance. For Controls Only: Patients with chronic liver disease without evidence of HCC confirmed by either : 1. a normal AFP level 2. a negative imaging study (ultrasound, CT, or MR imaging). 3. Negative liver cancer on explants. 1. Patients who declined to participate in the study 2. Patients with a history of HIV infection 3. Patients with concurrent advanced malignancy of nonhepatic origin. 4. Patients with significant use of androgenic steroid. 5. Patients with exposure to vinyl chloride.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>